Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Auris Medical advances tinnitus drug therapy development with funds from CHF47.1mm Series C round

Executive Summary

Auris Medical AG (developing drug therapies for inner ear disorders) raised CHF47.1mm ($50.3mm) through its Series C round. Sofinnova Ventures and Sofinnova Partners participated, and both gain representation on Auris’s board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies